Thursday - September 10, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Happy Farm Botanicals
September 10, 2026
WASHINGTON, Sept. 10 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Happy Farm Botanicals Inc. from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Hamed Alaghebandian, President, Happy Farm Botanicals, Inc., 3708 West Street, Hyattsville, MD 20785, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER< . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products